NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

Most hepatocellular carcinoma (HCC) patients are diagnosed at an advanced stage; however, the effect of systemic therapy on advanced HCC remains undetermined. Therefore, new treatment targets must be identified. We analyzed Gene Expression Omnibus datasets from two HCC patient cohorts and found that...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kang-Shuai, Zhu, Xiao-Dong, Liu, Hong-Da, Zhang, Shi-Zhe, Li, Xiao-Long, Xiao, Nan, Liu, Xue-Feng, Xu, Bin, Lei, Ming, Zhang, Yuan-Yuan, Shi, Wen-Kai, Cao, Man-Qing, Xu, Yun-Fei, Tang, Zhao-You, Sun, Hui-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206140/
https://www.ncbi.nlm.nih.gov/pubmed/32382041
http://dx.doi.org/10.1038/s41419-020-2549-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206140/
https://www.ncbi.nlm.nih.gov/pubmed/32382041
http://dx.doi.org/10.1038/s41419-020-2549-2

Ejemplares similares